Literature DB >> 31341050

Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice.

Rebecca S Treger1, Maria Tokuyama1, Huiping Dong1, Karen Salas-Briceno2, Susan R Ross2, Yong Kong3, Akiko Iwasaki4,5.   

Abstract

Endogenous retroviruses (ERV) are found throughout vertebrate genomes, and failure to silence their activation can have deleterious consequences on the host. Mutation and subsequent disruption of ERV loci is therefore an indispensable component of the cell-intrinsic defenses that maintain the integrity of the host genome. Abundant in vitro and in silico evidence have revealed that APOBEC3 cytidine-deaminases, including human APOBEC3G (hA3G), can potently restrict retrotransposition; yet, in vivo data demonstrating such activity is lacking, since no replication-competent human ERV have been identified. In mice deficient for Toll-like receptor 7 (TLR7), transcribed ERV loci can recombine and generate infectious ERV. In this study, we show that ectopic expression of hA3G can prevent the emergence of replication-competent, infectious ERV in Tlr7 -/- mice. Mice encode one copy of Apobec3 in their genome. ERV reactivation in Tlr7 -/- mice was comparable in the presence or absence of Apobec3 In contrast, expression of a human APOBEC3G transgene abrogated emergence of infectious ERV in the Tlr7 -/- background. No ERV RNA was detected in the plasma of hA3G+ Apobec3 -/- Tlr7 -/- mice, and infectious ERV virions could not be amplified through coculture with permissive cells. These data reveal that hA3G can potently restrict active ERV in vivo and suggest that expansion of the APOBEC3 locus in primates may have helped to provide for the continued restraint of ERV in the human genome.IMPORTANCE Although APOBEC3 proteins are known to be important antiviral restriction factors in both mice and humans, their roles in the restriction of endogenous retroviruses (ERV) have been limited to in vitro studies. Here, we report that human APOBEC3G expressed as a transgene in mice prevents the emergence of infectious ERV from endogenous loci. This study reveals that APOBEC3G can powerfully restrict active retrotransposons in vivo and demonstrates how transgenic mice can be used to investigate host mechanisms that inhibit retrotransposons and reinforce genomic integrity.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  APOBEC; Toll-like receptors; innate immunity; retroviruses

Mesh:

Substances:

Year:  2019        PMID: 31341050      PMCID: PMC6798113          DOI: 10.1128/JVI.00728-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  APOBEC3G incorporation into human immunodeficiency virus type 1 particles.

Authors:  Véronique Zennou; David Perez-Caballero; Heinrich Göttlinger; Paul D Bieniasz
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

Authors:  James A Dutko; Alexandra Schäfer; Alison E Kenny; Bryan R Cullen; M Joan Curcio
Journal:  Curr Biol       Date:  2005-04-12       Impact factor: 10.834

4.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

5.  Structure of endogenous murine leukemia virus DNA in mouse genomes.

Authors:  S K Chattopadhyay; M R Lander; E Rands; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

Review 6.  APOBEC3 Proteins in Viral Immunity.

Authors:  Spyridon Stavrou; Susan R Ross
Journal:  J Immunol       Date:  2015-11-15       Impact factor: 5.422

7.  Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.

Authors:  Audrey Low; Chioma M Okeoma; Nika Lovsin; Marcelo de las Heras; Thomas H Taylor; B Matija Peterlin; Susan R Ross; Hung Fan
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

8.  Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.

Authors:  Kun Luo; Tao Wang; Bindong Liu; Chunjuan Tian; Zuoxiang Xiao; John Kappes; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

9.  Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection.

Authors:  George R Young; Mickaël J-Y Ploquin; Urszula Eksmond; Munisch Wadwa; Jonathan P Stoye; George Kassiotis
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

10.  Induced prion protein controls immune-activated retroviruses in the mouse spleen.

Authors:  Marius Lötscher; Mike Recher; Karl S Lang; Alexander Navarini; Lukas Hunziker; Roger Santimaria; Markus Glatzel; Petra Schwarz; Jürg Böni; Rolf M Zinkernagel
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  9 in total

1.  Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice.

Authors:  Rebecca S Treger; Maria Tokuyama; Huiping Dong; Karen Salas-Briceno; Susan R Ross; Yong Kong; Akiko Iwasaki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  Murine Leukemia Virus Exploits Innate Sensing by Toll-Like Receptor 7 in B-1 Cells To Establish Infection and Locally Spread in Mice.

Authors:  Ruoxi Pi; Akiko Iwasaki; Xaver Sewald; Walther Mothes; Pradeep D Uchil
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

3.  Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus.

Authors:  Maria Tokuyama; Bronwyn M Gunn; Arvind Venkataraman; Yong Kong; Insoo Kang; Tasfia Rakib; Michael J Townsend; Karen H Costenbader; Galit Alter; Akiko Iwasaki
Journal:  J Exp Med       Date:  2021-05-21       Impact factor: 14.307

Review 4.  Structural Insights into APOBEC3-Mediated Lentiviral Restriction.

Authors:  Krista A Delviks-Frankenberry; Belete A Desimmie; Vinay K Pathak
Journal:  Viruses       Date:  2020-05-27       Impact factor: 5.048

5.  Retroviruses drive the rapid evolution of mammalian APOBEC3 genes.

Authors:  Jumpei Ito; Robert J Gifford; Kei Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

Review 6.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

Review 7.  Retroviral Restriction Factors and Their Viral Targets: Restriction Strategies and Evolutionary Adaptations.

Authors:  Guney Boso; Christine A Kozak
Journal:  Microorganisms       Date:  2020-12-11

Review 8.  Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression?

Authors:  Eros Di Giorgio; Luigi E Xodo
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

9.  Endogenous Retroviruses Provide Protection Against Vaginal HSV-2 Disease.

Authors:  Radeesha Jayewickreme; Tianyang Mao; William Philbrick; Yong Kong; Rebecca S Treger; Peiwen Lu; Tasfia Rakib; Huiping Dong; May Dang-Lawson; W Austin Guild; Tatiana J Lau; Akiko Iwasaki; Maria Tokuyama
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.